ArticleOncology letters2023

A retrospective study of the efficacy of combined EGFR‑TKI plus VEGF inhibitor/cytotoxic therapy vs. EGFR‑TKI monotherapy for PD‑L1‑positive EGFR‑mutant non‑small cell lung cancer: North Japan Lung Cancer Study Group 2202.

Minehiko Inomata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.